Huntington Beach, CA, United States of America

George R Ehring

USPTO Granted Patents = 15 

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 2002-2017

Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Mind of George R. Ehring: A Trailblazer in Pharmaceutical Patents

Introduction: George R. Ehring is a prominent inventor based in Huntington Beach, California, known for her significant contributions to the field of pharmaceuticals. With an impressive portfolio of 15 patents, she stands at the forefront of innovative research and development, particularly in the area of selective sodium current blockers.

Latest Patents: Among her latest inventions are notable patents related to benzimidazole derivatives that serve as selective blockers of persistent sodium currents. These compounds represent a significant advancement in the treatment of various conditions mediated by elevated persistent sodium currents, including ocular disorders, multiple sclerosis, seizure disorders, and chronic pain. The pharmaceutical compositions developed from her innovations hold the potential for transformative treatments in these challenging medical areas.

Career Highlights: George R. Ehring has made her mark in the pharmaceutical industry primarily through her work at Allergan, Inc. Her career reflects a dedication to research and innovation, resulting in the development of multiple compounds that can address critical health issues faced by patients today. Her impactful work in pharmacology speaks to her status as a leading inventor.

Collaborations: Throughout her career, George has collaborated with several esteemed colleagues, including Joseph S. Adorante and Larry Allen Wheeler. These relationships have fostered a productive environment for innovation, where ideas can be shared and developed into groundbreaking inventions.

Conclusion: George R. Ehring exemplifies the spirit of innovation within the pharmaceutical sector. Her extensive patent portfolio underscores her commitment to enhancing health outcomes through scientific advancement. As she continues her work at Allergan, her contributions are likely to leave a lasting impact on medicine and patient care for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…